Bong Koh, M.D.


Bong Koh, M.D., has served as a member of our board of directors since February 2021. Since 2009, Dr. Koh has served as partner at Venrock, a venture capital firm, where he focuses on Venrock's public and cross-over biotechnology fund. Dr. Koh previously served on the board of directors of AveXis, Inc. (acquired by Novartis International AG). He earned his B.A. in biology from Yale University, his M.D. from UC San Francisco, and his MBA from Harvard Business School.